-
Halozyme Therapeutics Inc. (HALO $74.93)
- $74.93 P/E (TTM): 17.12X Cap: $8.58B
- View HALO Profile
- View Questions on HALO
Detailed Quote
Questions on this company?
Become a Member
Company Profile
{tplLang.businessdescription | toLang tLang}
{ profileData.description }
{tplLang.details | toLang tLang}
{tplLang.ceo | toLang tLang}
{profileData.profile.details.ceo}
{tplLang.employees | toLang tLang}
{profileData.profile.details.employees | numeraljs '0,0'}
{tplLang.issuetype | toLang tLang}
{profileData.profile.details.issuetype | asIssueType}
{tplLang.industryclassifications | toLang tLang}
{tplLang.sector | toLang tLang}
{profileData.profile.classification.sector}
{tplLang.industry | toLang tLang}
{profileData.profile.classification.industry}
{tplLang.toolname| toLang tLang}
There is no {tplLang.toolname| toLang tLang} currently available for
{data.symbolstring}.
Interactive Chart
Key Ratios
Earnings
Analyst Recommendations
5i Recent Questions
-
Halozyme Therapeutics Inc. (HALO $74.93)
- $74.93 P/E (TTM): 17.12X Cap: $8.58B
- View HALO Profile
- View Questions on HALO
Q: There has been some recent news indicating a positive outlook for Halozyme Therapeutics future earnings. Please provide 5i's perspective.
Thank you, Patrick
Thank you, Patrick
Insiders
Share Information
SEC Filings
News and Media